1.. Introduction
================

Garlic, which is well-known for its characteristic odour, has various biological functions, such as antioxidant and antimicrobial effects ([@b1-etm-0-0-8385]--[@b3-etm-0-0-8385]). It is also known to be able to prevent atherosclerosis ([@b4-etm-0-0-8385]), diabetes ([@b5-etm-0-0-8385]), cardiac hypertrophy ([@b5-etm-0-0-8385]), thrombosis, inflammation, hypertension and even cancer ([@b6-etm-0-0-8385]--[@b9-etm-0-0-8385]). Garlic itself does not have any potent odour; however, when garlic bulbs are cut or crushed, a sulfuric odour is instantaneously produced. The major odour precursor is *S*-(+)-allyl-L-cysteine sulfoxide (*S*-2-propenyl cysteine sulfoxide; ACSO or alliin). When cells are damaged, ACSO is decomposed to produce garlic odour compounds, such as diallyl disulfide (di-2-propenyl disulfide; DADS) and diallyl trisulfide (di-2-propenyltrisulfide; DATS). These sulfides are the functional compounds that are responsible for the beneficial physiological activities of garlic ([@b10-etm-0-0-8385]); however, as they are lipophilic, volatile and have a strong odour, their use in foods is limited. On the other hand, ACSO is hydrophilic and odourless, rendering it useful as an additive in a wide range of foods. In light of recent findings, this review summarizes the characteristics and physiological functions of ACSO *in vivo*.

2.. Characteristics of ACSO
===========================

ACSO is an amino acid that contains an amino group and carboxyl group in its structure with a molecular weight of 177.22. According to the substance information in Chemical Abstracts (SciFinder Scholar), the physicochemical properties of ACSO are estimated. The density, pKa, and boiling point of ACSO are predicted to be 1.354 g/ml at 20°C, 1.88 at 25°C and 416°C, respectively, according to calculations of the Advanced Chemistry Development (ACD/Labs) software v11.02. Furthermore, the melting point is 165°C according to PhysProp data obtained from the Syracuse Research Corporation. The mass solubilities at pH 1, 2, 3--6, 7, 8, 9 and 10, as predicted by the ACD/Labs Software v11.02, are 120, 35, 27, 32, 76, 535 and 1,000 g/l, respectively, and ACSO is quite soluble in solutions above pH 9. ACSO itself is odourless and enhances sweet, salty and umami tastes ([@b11-etm-0-0-8385]). Therefore, ACSO may be one of the key components that produce a rich flavour in garlic-containing foods.

3.. Biosynthesis of ACSO
========================

The biosynthesis of ASCO is presented in [Fig. 1](#f1-etm-0-0-8385){ref-type="fig"}. Although several biosynthetic pathways for ACSO have been proposed, its biosynthesis remains under debate ([@b12-etm-0-0-8385]--[@b14-etm-0-0-8385]). Tracing the radioactivity of labelled valine reveals that the radioactivity is located in the carboxypropyl group of *S*-2-carboxypropyl glutathione and *S*-2-carboxypropyl cysteine ([@b15-etm-0-0-8385]). *S*-2-Carboxypropyl glutathione is biosynthesized from glutathione (a tripeptide comprised of glycine, cysteine, and glutamic acid) with methacrylic acid produced from valine. However, two possible pathways forming *S*-2-carboxypropyl cysteine have been reported. One mechanism involves γ-glutamyl *S*-2-carboxypropyl cysteine produced from *S*-2-carboxypropyl glutathione via elimination of glycine, while the other involves generation from cysteine and methacrylic acid without passing through glutathione. These routes have also been proposed for the biosynthesis of *trans*-1-propenyl cysteine in onion ([@b12-etm-0-0-8385]). *S*-2-Carboxypropyl glutathione may also be produced from cysteine, as γ-glutamyl cysteine is detected in garlic ([@b16-etm-0-0-8385]). As decarboxylation and oxidation of the carboxypropyl group produce an allyl group ([@b13-etm-0-0-8385]), γ-glutamyl *S*-allyl cysteine can be produced from γ-glutamyl *S*-2-carboxypropyl cysteine, and *S*-allyl cysteine can be produced from *S*-2-carboxypropyl cysteine. The *S*-oxidation of γ-glutamyl *S*-allyl cysteine forms γ-glutamyl *S*-allyl cysteine sulfoxide, while that of *S*-allyl cysteine forms ACSO. Flavin-containing monooxygenase (FMO) in the cytosol is responsible for the *S*-oxidation in the biosynthesis of ACSO in the presence of nicotinamide adenine dinucleotide phosphate (NADPH) and flavin adenine dinucleotide (FAD) ([@b17-etm-0-0-8385]). On the other hand, the recombinant γ-glutamyl transpeptidase (GGT) prepared by cloning genes from garlic exhibits a high specificity for γ-glutamyl *S*-allyl cysteine, but not for γ-glutamyl *S*-allyl cysteine sulfoxide ([@b18-etm-0-0-8385]). Therefore, *S*-allyl cysteine produced from the deglutamylation of γ-glutamyl *S*-allyl cysteine forms ACSO via its *S*-oxidation, and the pathway via γ-glutamyl *S*-allyl cysteine sulfoxide to ACSO may not exist in garlic. The observations that ACSO can be produced with the addition of *S*-allyl cysteine in garlic callus ([@b14-etm-0-0-8385]) and that *S*-allyl cysteine is found in garlic ([@b19-etm-0-0-8385],[@b20-etm-0-0-8385]), also support this biosynthetic route from *S*-allyl cysteine to ACSO. As the addition of serine and allyl thiol produces ACSO ([@b12-etm-0-0-8385]), the pathway from serine via *S*-allyl cysteine to form ACSO is also probable.

The location of ACSO biosynthesis has not yet been convincingly identified. γ-Glutamyl peptides reside in the cytoplasm and cysteine sulfoxides in the cytoplasm or cytoplasmic vesicle, while γ-glutamyl cysteine resides in the chloroplast ([@b13-etm-0-0-8385]) ([Fig. 2](#f2-etm-0-0-8385){ref-type="fig"}). As for the enzymes required for biosynthesis, γ-glutamyl cysteine synthetase is located in the chloroplast, and γ-glutamyl transpeptidase and flavin-containing monooxygenase are located in the cytoplasm ([@b13-etm-0-0-8385]).

4.. Content of ACSO and related compounds in garlic
===================================================

The majority of the organosulfur compounds in garlic are γ-glutamyl *S*-alkenyl cysteines and cysteine sulfoxides ([@b21-etm-0-0-8385],[@b22-etm-0-0-8385]), with ACSO being the major component. The ACSO content in fresh garlic is 3--14 mg/g fresh weight ([@b20-etm-0-0-8385],[@b23-etm-0-0-8385],[@b24-etm-0-0-8385]) and 20--30 mg/g dry weight ([@b25-etm-0-0-8385],[@b26-etm-0-0-8385]). As regards other cysteine sulfoxides, the contents of *S*-methyl-L-cysteine sulfoxide (MCSO or methiin), *trans-S*-1-propenyl-L-cysteine sulfoxide (PeCSO or isoalliin) and cycloalliin are 0.5--2, 0.1--1.2 and 0.5--1.5 mg/g fresh weight, respectively ([@b24-etm-0-0-8385]). γ-L-Glutamyl-*S*-allyl-L-cysteine content in garlic bulbs is 2--7 mg/g fresh weight ([@b21-etm-0-0-8385],[@b24-etm-0-0-8385]) and 3--20 mg/g dry weight ([@b26-etm-0-0-8385]), while the γ-L-glutamyl-*S*-(*trans*-1-propenyl)-L-cysteine content is 3--9 mg/g fresh weight ([@b21-etm-0-0-8385],[@b24-etm-0-0-8385]) and 5--15 mg/g dry weight ([@b26-etm-0-0-8385]). γ-L-Glutamyl-*S*-methyl-L-cysteine is present at 0.1--0.4 mg/g fresh weight ([@b24-etm-0-0-8385]).

Sulfur fertilization increases the ACSO content in garlic cloves, while nitrogen fertilization decreases this content ([@b27-etm-0-0-8385]). Irrespective of the fertilization conditions, the ACSO content increases during storage at 20°C and decreases during storage at temperatures \>35°C ([@b28-etm-0-0-8385]). Drying at 60°C does not affect the ACSO content ([@b29-etm-0-0-8385]).

ACSO accumulates in leaves during early growth stages and translocates to the bulbs during bulb formation ([@b30-etm-0-0-8385]). Approximately 85% of ACSO is present in the bulbs, with approximately 12% in the leaves and 2% in the roots, while γ-glutamyl cysteines are found only in the bulbs ([@b24-etm-0-0-8385]). The γ-glutamyl-cysteine content in the bulbs increases a few weeks prior to harvest ([@b25-etm-0-0-8385],[@b31-etm-0-0-8385]). The ACSO content in the bulbs also begins to increase a few weeks prior to harvest ([@b25-etm-0-0-8385],[@b31-etm-0-0-8385]) but also further increases during the curing process (drying process after harvest for storage) ([@b21-etm-0-0-8385]). The content of ACSO in the leaves, however, remains relatively stable from 6 weeks to 1 week prior to harvest and subsequently decreases.

5.. Decomposition of ACSO and other sulfoxides
==============================================

The decomposition of ASCO and other sulfoxides is illustrated in [Figs. 3](#f3-etm-0-0-8385){ref-type="fig"} and [4](#f4-etm-0-0-8385){ref-type="fig"}. When garlic bulbs are sliced or ground during cooking, ACSO that resides in the cytoplasm or cytoplasmic vesicle of all cells ([@b13-etm-0-0-8385]) binds alliinase (C-S lyase; EC 4.4.1.4) that localizes in the vacuoles of vascular bundle sheath cells located around the veins or phloem ([@b32-etm-0-0-8385]). Alliinase belongs to a class 1 family of pyridoxal-5′-phosphate-dependent enzymes ([@b2-etm-0-0-8385]) and is a homodimeric glycoprotein, consisting of 448-amino-acid subunits with a molecular weight of 51,500 Da each ([@b2-etm-0-0-8385]). Two alliinase isozymes have been identified in garlic: One is specific for ACSO and PeCSO, and the other is specific for MCSO ([@b22-etm-0-0-8385]). ACSO is converted to allylsulfenic acid (2-propene-1-sulfenic acid; CH~2~=CHCH2SOH) ([@b33-etm-0-0-8385]) and aminoacrylic acid by alliinase. Aminoacrylic acid is then spontaneously converted to pyruvic acid and ammonia. Two molecules of allylsulfenic acid produce diallyl thiosulfinate (*S*-prop-2-en-1-yl prop-2-ene-1-sulfinothioate; allicin), which exerts strong antimicrobial activity ([@b34-etm-0-0-8385]--[@b37-etm-0-0-8385]). The amount of allicin produced is approximately 0.1 to 7 mg/g fresh weight due to the abundance of ACSO in garlic ([@b7-etm-0-0-8385],[@b38-etm-0-0-8385]). The incorporation of an additional allylsulfenic acid and the removal of allyl alcohol yield 1,3-di(prop-2-en-1-yl)trisulfane 1-oxide. When garlic bulbs are homogenized in water or in an alcohol solution, DADS and DATS are mainly produced from the diallyl thiosulfinate and 1,3-di(prop-2-en-1-yl)trisulfane 1-oxide. Volatile oil obtained from garlic products by steam distillation contains DADS and DATS as the major components ([@b38-etm-0-0-8385]). These sulfides are known to have various physiological activities ([@b10-etm-0-0-8385],[@b39-etm-0-0-8385]); however, they are lipophilic and have a potent garlic odour. On the other hand, when garlic bulbs are homogenized in oil or in non-polar solvent, dithiins become dominant, 2-vinyl-4*H*−1,3-dithiin and 3-vinyl-4*H*−1,2-dithiin being about 0.4 mg/g and 0.17 mg/g, respectively ([@b38-etm-0-0-8385]). Other components produced are (*E*)-ajoene (0.07 mg/g), (*Z*)-ajoene (0.04 mg/g), DATS (0.07 mg/g), methyl allyl trisulfide (MATS) (0.06 mg/g) and DADS (0.03 mg/g).

As MCSO is the second most abundant cysteine sulfoxide in garlic, representing approximately 10% of the total cysteine sulfoxides, the compounds produced from MCSO contribute to the composition of volatile oil. MCSO is also decomposed by alliinase when garlic is sliced or grated to yield methylsulfenic acid ([Fig. 4](#f4-etm-0-0-8385){ref-type="fig"}). Allylsulfenic acid produced from ACSO and methylsulfenic acid produced from MCSO form *S*-methyl prop-2-ene-1-sulfinothioate and *S*-prop-2-en-1-yl methanesulfinothioate, the latter being twice as abundant at the former, though allicin accounts for 60--90% of the total thiosulfinates. The *S*-methyl prop-2-ene-1-sulfinothioate and *S*-prop-2-en-1-yl methanesulfinothioate form methyl allyl disulfide (MADS) and MATS. Importantly, the ratio of allyl groups and methyl groups in total thiosulfinates almost directly coincides with that in total *S*-alk(en)yl-L-cysteine sulfoxides in garlic ([@b40-etm-0-0-8385]). Among the sulfides, DATS (0.8--1.1 mg/g) and DADS (0.5--1 mg/g) are the most abundant, with MATS (0.2--0.7 mg/g) and MADS (0.08--0.5 mg/g) as the next most abundant. Dimethyl trisulfide (DMTS; 0.01--0.1 mg/g) and dimethyl disulfide (DMDS; 0.001--0.06 mg/g) occur in smaller quantities.

6.. Metabolism of ACSO
======================

The metabolism of ASCO is illustrated in [Fig. 5](#f5-etm-0-0-8385){ref-type="fig"}. When 10 ml of 100 mM ACSO/kg body weight is injected into the ligated loop of the small intestine of rats, both ACSO and pyruvic-acid concentrations in the portal vein increase to approximately 4 and 0.2 mM, respectively, after 30 min ([@b41-etm-0-0-8385]), indicating that ACSO is mostly absorbed from the small intestine into the blood in the intact form; however, it is also partly converted to allylsulfenic acid, pyruvic acid and ammonia. In addition, mixing ACSO with crude proteins extracted from the small intestine of rats yields DADS and DAS as volatile compounds ([@b41-etm-0-0-8385]), supporting the assumption that ACSO is decomposed to allylsulfenic acid and two molecules of allylsulfenic acid produce DADS and DAS via allicin. Therefore, ACSO may follow the same fate as allicin and DADS in the body. When garlic oil is consumed, DADS, DAS and DMDS are detected in urine ([@b42-etm-0-0-8385]). When garlic extract is consumed, *N*-acetyl-*S*-allyl-L-cysteine (allylmercapturic acid) is identified in urine ([@b43-etm-0-0-8385],[@b44-etm-0-0-8385]). *N*-Acetyl-L-cysteine (mercapturic acid; MA) conjugates are commonly formed from glutathione conjugates. The glutathione conjugates are first transformed into L-cysteine conjugates via the elimination of glutamic acid by γ-glutamyl transpeptidase and glycine by cysteinylglycinase. Subsequently, L-cysteine conjugates are *N*-acetylated by cysteine-S-conjugate *N*-acetyltransferase to form MA conjugates ([@b43-etm-0-0-8385]). Allicin reacts with glutathione to produce *S*-allyl-mercaptoglutathione or with L-cysteine to produce *S*-allyl-mercaptocysteine *in vivo* ([@b45-etm-0-0-8385]). DADS undergoes nucleophilic substitution at the α-carbon in a reaction with glutathione to yield *S*-allyl-glutathione and allyl perthiol. This *S*-allyl-glutathione is then converted to *S*-allyl cysteine by γ-glutamyl transpeptidase and cysteinylglycinase. The *S*-allyl cysteine is further transformed into *N*-acetyl-*S*-allyl-L-cysteine via *N*-acetylation by the cysteine-S-conjugate *N*-acetyltransferase ([@b46-etm-0-0-8385]).

7.. Physiological functions of ACSO
===================================

Orally administered ACSO ameliorates the diabetic condition ([@b47-etm-0-0-8385],[@b48-etm-0-0-8385]). When diabetes is induced in rats by an injection of alloxan monohydrate, fasting blood glucose levels are reduced, and insulin secretion is increased by the daily oral administration of 200 mg ACSO/kg body weight. In addition, orally administered ACSO reduces the generation of reactive aldehydes produced by lipid peroxidation, increasing catalase activity and glutathione content ([@b47-etm-0-0-8385]). Similar effects have been observed in mice with diet-induced obesity (DIO) ([@b48-etm-0-0-8385]). When these mice are fed a high-fat (60% kcal from fat) diet for 8 weeks and provided with water containing 0.1 mg ACSO/ml for a further 8 weeks, glucose homeostasis and insulin sensitivity are enhanced. The increase in blood glucose levels following the injection of glucose is suppressed, and the decrease in blood glucose level following the injection of insulin is promoted. In addition, ACSO administration improves the lipid profile and liver functions of the mice with DIO. ACSO treatment reduces the levels of triglycerides, low-density lipoprotein and non-esterized free fatty acid. It also decreases the activities of aspartate aminotransferase and alkaline phosphatase, and the levels of total protein and albumin in the blood ([@b48-etm-0-0-8385]).

Furthermore, ACSO has been shown to prevent myocardial ischaemia induced by isoproterenol in rats ([@b49-etm-0-0-8385]). When 40 or 80 mg ACSO/kg body weight is administered to rats for 5 weeks, the increase in the activities of creatine kinase, lactate dehydrogenase, aspartate transaminase and alanine transferase in serum, and their decrease in the heart due to the induction of myocardial ischaemia are both suppressed. In addition, ACSO administration suppresses the increase in 3-hydroxy 3-methyl glutaryl coenzyme A (HMG CoA) reductase activity in the liver and the decrease in lecithin cholesterol acyl transferase activity in the liver and heart in these isoproterenol-treated rats ([@b49-etm-0-0-8385]). The increase in the levels of plasma thiobarbituric acid reactive substances and hydroperoxide in mice with myocardial-ischaemia-induced is also suppressed by ACSO administration.

ACSO has also been shown to suppress oxidative stress in rats with carbon tetrachloride (CCl~4~)-induced hepatic injury ([@b41-etm-0-0-8385]). In rats with hepatic injury, following the oral administration of 50 µmol ACSO for 7 days, the increased aspartate transaminase, alanine transaminase and lactate dehydrogenase activities as well as the amount of thiobarbituric acid reactive substances are suppressed. In addition, the decrease in glutathione levels and the activities of glutathione *S*-transferase and glutathione peroxidase are also suppressed. These observations indicate that ACSO prevents hepatic injury by enhancing the activities of phase II detoxifying enzymes and reducing oxidative stress. As MCSO, *S*-ethyl-L-cysteine sulfoxide (ECSO) and *S*-allyl-L-cysteine (ACS) are not effective for the prevention of hepatic injury, the allyl and sulfoxide groups in ACSO are essential for this preventive effect. Moreover, ACSO promotes nuclear factor erythroid 2-related factor 2 (Nrf2) nuclear translocation in HepG2 cells, leading to the induction of antioxidant and detoxifying enzymes, and contributing to these preventive effects ([@b41-etm-0-0-8385]).

In garlic, some of the sulfides, such as MATS and DMTS, exhibit inhibitory activity against platelet aggregation *in vitro* ([@b50-etm-0-0-8385]). As thrombosis is triggered by platelet aggregation, these sulfides may be the factors responsible for the prevention of thrombosis following garlic consumption. The administration of ACSO to rats, however, results in greater inhibitory activity against platelet aggregation than DADS ([@b51-etm-0-0-8385]). The effect of ACSO is most potent at a dosage of 10 mg/kg body weight, and the duration of the effect persists for 16--24 h following administration. Although DADS is produced during the absorption of ACSO from the small intestine ([@b41-etm-0-0-8385]), the functional component is assumed to be different, suggesting the *in vivo* production of potent ACSO metabolites that confer inhibitory activity against platelet aggregation.

Finally, ACSO suppresses the increase in blood ethanol concentration following the oral administration of ethanol and ACSO together ([@b52-etm-0-0-8385]). Although the supply of NAD+ is the rate-limiting factor for the metabolism of ethanol to acetaldehyde, and NAD+ is produced from NADH during the conversion of pyruvic acid to lactic acid by lactate dehydrogenase, pyruvate production during the absorption of ACSO from the small intestine is not responsible for this suppressive effect on blood ethanol elevation. The administration of pyruvic acid at levels equivalent to those of ACSO does not exert the suppressive effect on blood ethanol elevation. The mechanisms underlying the reduction in blood ethanol concentrations by ACSO involve the promotion of ethanol metabolism in the liver and the suppression of ethanol absorption from the gut ([@b52-etm-0-0-8385]). Specifically, ACSO induces the activities of alcohol dehydrogenase, which converts ethanol into acetaldehyde, and aldehyde dehydrogenase, which converts acetaldehyde into acetic acid. In addition, the injection of ACSO into the ligated stomach or small intestine together with ethanol results in the suppression of the increase in ethanol concentration in the portal vein, indicating overall suppression of ethanol absorption. Garlic extract rich in ACSO (Garlic-H) exhibits an effect similar to ACSO itself, while garlic extract that does not contain ACSO (Garlic-N) exerts less-potent effects compared to Garlic-H ([@b52-etm-0-0-8385]).

8.. Conclusions
===============

On the whole, as discussed in this review article, the physiological functions of ACSO are extensive and can be applied to promote human health. As ACSO is water-soluble and odourless and enhances taste, the addition of this garlic component to food products will provide both a rich flavour and may confer numerous health benefits.
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